Patient-derived xenografts for individualized care in advanced sarcoma

By Stebbing Justin   Paz Keren   Schwartz Gary K.   Wexler Leonard H.   Maki Robert   Pollock Raphael E.   Morris Ronnie   Cohen Richard   Shankar Arjun   Blackman Glen   Harding Victoria   Vasquez David   Krell Jonathan   Ciznadija Daniel   Katz Amanda   Sidransky David  

Cancer, Vol. 120, Iss. 13, 2014-07 ,pp. : 2006-2015

Blackwell Publishing

Access to resources Recommend Favorite

Patient-derived sarcoma xenografts for individual-patient selection of chemotherapy—ready for prime time?

By Wagner Andrew J.  

Cancer, Vol. 120, Iss. 13, 2014-07 ,pp. : 1917-1919

Blackwell Publishing

Access to resources Recommend Favorite

Are we ready to take full advantage of patient‐derived tumor xenograft models?

By  

Hematological Oncology (Electronic), Vol. 36, Iss. 1, 2018-02 ,pp. : 24-27

John Wiley & Sons Inc

Access to resources Recommend Favorite

Patient-derived Tumor Models for Diffuse Intrinsic Pontine Gliomas

By  

Current Neuropharmacology, Vol. 15, Iss. 1, 2016-12 ,pp. : 98-103

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Delivery of Tumor Suppressor microRNA-1 by Transferrin- Conjugated Lipopolyplex Nanoparticles to Patient-Derived Glioblastoma Stem Cells

By  

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 9, 2014-09 ,pp. : 839-846

Bentham Science Publishers

Access to resources Recommend Favorite